Our Network of Board-Certified Providers
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
If you live in the Rim Area area of El Paso, Texas, Made Peptide brings fully personalized peptide therapy directly to your door. El Paso County residents receive a physician-designed custom plan — not a one-size-fits-all prescription. Your physician evaluates your individual health profile and builds a dosing schedule calibrated specifically for your body.
Peptide medications — including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — are prescribed by TX-licensed doctors via telehealth and delivered to your El Paso home. Your custom plan ensures optimal dosing for residents of Rim Area and surrounding El Paso County neighborhoods.[1][2]
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 4, 2026
Weekly semaglutide (Ozempic for glycemic control, Wegovy for weight management) is prescribed by licensed physicians following evidence-based dose-escalation protocols. Dosing is individualized according to patient response, comorbidities, and the published STEP 1 trial titration methodology.
Tirzepatide's dual GIP/GLP-1 mechanism achieves superior weight reduction compared to single GLP-1 agonists in head-to-head clinical analyses. Physicians specializing in obesity medicine apply specific patient eligibility criteria and 20-week dose-escalation protocols for Mounjaro and Zepbound to maximize clinical outcomes.
Landmark randomized controlled trials in the New England Journal of Medicine establish the efficacy profile of FDA-approved GLP-1 medications available to Rim Area, El Paso residents:
Telehealth prescribing of GLP-1 receptor agonists in Texas is conducted by board-certified, TX-licensed physicians through HIPAA-compliant platforms. GLP-1 medications are not DEA-scheduled controlled substances and may be prescribed via telehealth after a valid clinical evaluation.
Your custom peptide plan in Rim Area is built around your body — a physician-supervised, personalized process from assessment through active treatment. Every phase is designed to maximize your individual results.
Complete a detailed health questionnaire from your home in Rim Area. It covers your weight history, metabolic health, current medications, and goals — giving your physician everything needed to build a custom peptide plan calibrated for your specific body.
A TX-licensed physician reviews your assessment and conducts a telehealth consultation. They select the appropriate peptide agent, establish your personalized titration schedule, and outline what to expect at each plan milestone. You begin with a roadmap built for your body.
Your peptide medication ships from a licensed US pharmacy to your Rim Area address within 3-5 business days. Your custom plan begins immediately — with scheduled physician check-ins at each dose milestone to monitor your individual progress and update your plan as needed.
Personalized peptide weight loss plans serve all neighborhoods in El Paso and the surrounding area.
Custom peptide plans are available throughout El Paso, TX — personalized therapy in every neighborhood.
Personalized peptide therapy plans are available in cities near El Paso through our licensed physician network.
Personalized peptide therapy is available in the largest cities across Texas.
Our national GLP-1 telehealth network connects neighborhood residents with licensed physicians for evidence-based, physician-guided weight management care.
Local weight loss and GLP-1 providers serving the Rim Area, El Paso, TX area, based on Google Business listings.
1155 Westmoreland Dr suite 122, El Paso, TX 79925
4.7/5 ★ (78 reviews)
11355 Montwood Dr A
4.9/5 ★ (73 reviews)
5625 Woodrow Bean Transmountain Suite 103
4.9/5 ★ (35 reviews)
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
A custom peptide plan for Rim Area residents is a physician-designed, personalized approach to peptide weight loss therapy. It begins with a comprehensive health assessment, selects the appropriate FDA-approved peptide medication (semaglutide, tirzepatide, or liraglutide), and builds a dosing schedule calibrated specifically for your body — monitored by a TX-licensed physician through regular telehealth check-ins.
All peptide medications prescribed in your custom plan ship from licensed US pharmacies directly to your Rim Area home. Delivery to El Paso County typically takes 3-5 business days. Your medication arrives with personalized dosing instructions from your physician — no pharmacy visits required.
Patients on custom peptide plans achieve 15% average weight reduction with semaglutide and up to 22% with tirzepatide over 68-72 weeks, based on clinical trial data. Most Rim Area plan patients begin noticing appetite reduction within the first 2 weeks and measurable weight loss by week 8.
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
